Thomas J. Polascik MD, FACSProfessor of Surgery; Director, Urologic Oncology Fellowship; Director, GU Program on Focal Therapy, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina
Dr. Thomas Polascik is a professor of surgery, the director of the Urologic Oncology Program, and the director of the Genitourinary Program on Focal Therapy at Duke Cancer Institute in Durham, North Carolina.
Dr. Polascik received his medical degree from the University of Chicago Pritzker School of Medicine. He did his residency training in general surgery at Johns Hopkins Hospital in Baltimore, Maryland, and in urology at the James Buchanan Brady Urological Institute at Hopkins. He also completed a fellowship in urologic oncology at Johns Hopkins Hospital
His clinical interests include nerve-sparing focal therapy for prostate cancer and minimally invasive surgery for kidney tumors, as well as urologic oncology.
Recent Contributions to PracticeUpdate:
- Focal vs Whole Gland Ablation for Prostate Cancer in Terms of Sexual Function and Urinary Continence
- Salvage Radical Prostatectomy Following Focal Therapy
- Systematic Biopsy vs MRI and Targeted and Systematic Biopsy in Men on Active Surveillance
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
- Primary Whole-Gland Cryoablation for Prostate Cancer
- Whole-Gland Ablation of Localized Prostate Cancer With High-Intensity Focused Ultrasound